Cargando…
Worsening Endothelial Function with Efavirenz Compared to Protease Inhibitors: A 12-Month Prospective Study
OBJECTIVE: Changes in endothelial function, measured as flow-mediated dilation (FMD) of the brachial artery, has not been systematically assessed beyond 6 months of initiation of antiretroviral therapy (ART) when drug-related effects might offset initial improvements with virologic control. DESIGN:...
Autores principales: | Gupta, Samir K., Shen, Changyu, Moe, Sharon M., Kamendulis, Lisa M., Goldman, Mitchell, Dubé, Michael P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447812/ https://www.ncbi.nlm.nih.gov/pubmed/23029197 http://dx.doi.org/10.1371/journal.pone.0045716 |
Ejemplares similares
-
Suppression of HIV in the first 12 months of antiretroviral therapy: a comparative analysis of dolutegravir- and efavirenz-based regimens
por: da Silva, Gabriella Jomara, et al.
Publicado: (2023) -
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
por: Swindells, Susan, et al.
Publicado: (2005) -
Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America
por: Caro-Vega, Yanink, et al.
Publicado: (2018) -
Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens
por: Rosenblatt, Lisa, et al.
Publicado: (2016) -
Efavirenz and neuropsychiatric effects
por: Dheda, Mukesh
Publicado: (2017)